Diagnostic and therapeutic considerations on inherited platelet disorders in neonates and children

N Schlegel1, V Bardet, G Kenet

  • 1Service d'Hématologie Biologique, Hôpital Robert Debré, Paris, France.

Klinische Padiatrie
|June 11, 2010
PubMed

Insights

Diagnosing inherited platelet function disorders in children requires understanding pediatric platelet physiology. This overview details diagnostic strategies and treatments for these rare bleeding conditions in early childhood.

Area of Science:

  • Hematology
  • Pediatric Medicine
  • Rare Diseases

Background:

  • Inherited platelet disorders cause bleeding syndromes of varying severity, often diagnosed in infancy or childhood.
  • Accurate diagnosis in early childhood necessitates understanding pediatric platelet physiology.
  • Thrombocytopenia is common in neonates and children, but this review focuses on inherited platelet function disorders.

Purpose of the Study:

  • To provide an overview of inherited platelet function disorders in pediatric populations.
  • To present age-specific platelet maturation and reference values.
  • To outline a diagnostic strategy tailored for children, incorporating laboratory and molecular methods.

Main Methods:

  • Review of current literature on pediatric platelet physiology and inherited disorders.
  • Description of diagnostic approaches using plasmatic and molecular laboratory methodologies.
  • Summary of therapeutic interventions for inherited platelet function disorders.

Main Results:

  • Established the importance of age-specific knowledge for diagnosing pediatric platelet function disorders.
  • Presented a diagnostic strategy adapted for the pediatric population.
  • Summarized available therapeutic options, including antifibrinolytic agents, Desmopressin, HLA-matched platelets, and recombinant factor VIIa.

Conclusions:

  • Accurate diagnosis of inherited platelet function disorders in children relies on understanding pediatric platelet physiology.
  • A tailored diagnostic strategy combining laboratory and molecular methods is crucial for early detection.
  • Various therapeutic approaches exist to manage these rare bleeding conditions in pediatric patients.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...